Accelerize Inc. owns and operates CAKE and getcake.com, a marketing technology that provides a suite of marketing intelligence tools. The Company's software-as-a service (SaaS) is an enterprise solution, which provides online tracking and analytics solutions for advertisers and online marketers. The Company provides software solutions for businesses interested in optimizing their digital advertising spend. The Company's CAKE for Advertisers allows brands to track, attribute and optimize digital marketing campaigns in real-time. The Company's CAKE SaaS marketing platform is used by various companies and customer-base of enterprise performance marketing networks and advertisers. Its CAKE platform supports multiple languages and currencies so online marketers can track the performance of their marketing campaigns and target their digital spend on a global scale. The Company's CAKE allows users to qualify their leads using business rules, reducing the number of fraudulent leads.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:ACLZ
- CUSIP: N/A
- Web: accelerize.com/
- 50 Day Moving Avg: $0.29
- 200 Day Moving Avg: $0.37
- 52 Week Range: $0.28 - $0.58
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: $23.85 million
- Price / Sales: N/A
- Book Value: ($0.06) per share
- Price / Book: -4.83
- EBIDTA: $811,106.00
- Net Margins: -0.93%
- Return on Assets: -3.12%
- Average Volume: 47,967 shs.
Frequently Asked Questions for Accelerize (NASDAQ:ACLZ)
What is Accelerize's stock symbol?
Accelerize trades on the NASDAQ under the ticker symbol "ACLZ."
How were Accelerize's earnings last quarter?
Accelerize Inc (NASDAQ:ACLZ) released its quarterly earnings results on Monday, August, 8th. The company reported ($0.01) earnings per share for the quarter. The firm earned $6 million during the quarter, compared to the consensus estimate of $6.29 million. View Accelerize's Earnings History.
Who are some of Accelerize's key competitors?
Some companies that are related to Accelerize include Evoke Pharma (EVOK), BioSig Technologies (BSGM), Odyssey Marine Exploration (OMEX), CafePress (PRSS), Caladrius Biosciences (CLBS), Nivalis Therapeutics (NVLS), Orexigen Therapeutics (OREX), Trillium Therapeutics (TRIL), Clean Diesel Technologies (CDTI), Mid-Con Energy Partners, LP (MCEP), TRACON Pharmaceuticals (TCON), TrovaGene (TROV), Bio-Path Holdings (BPTH), Dimension Therapeutics (DMTX), Ohr Pharmaceuticals (OHRP), Cemtrex (CETX), Presbia PLC (LENS) and Medley Management (MDLY).
Who are Accelerize's key executives?
Accelerize's management team includes the folowing people:
- Brian S. Ross, Chairman of the Board, President, Chief Executive Officer, Treasurer
- Anthony P. Mazzarella, Chief Financial Officer, Executive Vice President
- Santi A Pierini, Chief Operating Officer, President of our CAKE division
- David Stewart, Chief Technology Officer
- Charles Teed, Vice President - Sales
- Chirag Mehta, Vice President - Client Success
- Damon S. Stein, General Counsel, Secretary
- Erik Charles, Senior Director - Product Marketing
- Gregory Akselrud, Independent Director
- Mario Marsillo Jr., Independent Director
How do I buy Accelerize stock?
Shares of Accelerize can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Accelerize's stock price today?
MarketBeat Community Rating for Accelerize (NASDAQ ACLZ)MarketBeat's community ratings are surveys of what our community members think about Accelerize and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Accelerize stock can currently be purchased for approximately $0.29.
Consensus Ratings for Accelerize (NASDAQ:ACLZ) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Accelerize (NASDAQ:ACLZ)
(Data available from 7/26/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
Earnings History for Accelerize (NASDAQ:ACLZ)Earnings History by Quarter for Accelerize (NASDAQ ACLZ)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/8/2016||Q2 2016||($0.01)||$6.29 million||$6.00 million||View||N/A|
|5/11/2016||Q1 2016||($0.01)||($0.01)||$5.98 million||$5.86 million||View||N/A|
|8/13/2015||Q2 2015||($0.03)||($0.03)||$5.39 million||$5.47 million||View||N/A|
|5/12/2015||Q1 2015||($0.02)||($0.03)||$4.97 million||$5.20 million||View||N/A|
|3/19/2015||Q4 2014||($0.02)||($0.01)||$4.81 million||View||N/A|
Earnings Estimates for Accelerize (NASDAQ:ACLZ)
Current Year EPS Consensus Estimate: $0.00 EPS
Next Year EPS Consensus Estimate: $0.02 EPS
Dividend History for Accelerize (NASDAQ:ACLZ)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Accelerize (NASDAQ:ACLZ)Insider Trades by Quarter for Accelerize (NASDAQ:ACLZ)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|5/16/2017||Brian S Ross||Chairman||Buy||16,923||$0.36||$6,092.28|| |
|12/15/2016||Brian S Ross||Chairman||Buy||11,000||$0.52||$5,720.00|| |
|12/15/2016||Damon S Stein||General Counsel||Buy||10,000||$0.52||$5,200.00|| |
|12/12/2016||Jr. Mario Marsillo||Director||Buy||50,000||$0.54||$27,000.00|| |
|12/9/2016||Santi Pierini||COO||Buy||18,655||$0.44||$8,208.20|| |
|12/6/2016||Anthony P Mazzarella||CFO||Buy||20,200||$0.45||$9,090.00|| |
|12/5/2016||Brian S Ross||Chairman||Buy||30,000||$0.47||$14,100.00|| |
|3/15/2013||Brian S Ross||CEO||Buy||4,000||$0.89||$3,560.00|| |
|3/13/2013||Brian S Ross||CEO||Buy||5,000||$0.79||$3,950.00|| |
Headline Trends for Accelerize (NASDAQ:ACLZ)
Latest Headlines for Accelerize (NASDAQ:ACLZ)
Accelerize (ACLZ) Chart for Wednesday, July, 26, 2017